SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of OvaScience, Inc. (OVAS)

NEW YORK, Jan. 25, 2016

This investigation concerns whether OvaScience, Inc. and certain of its officers and/or directors have violated the Federal Securities Laws under the Securities Exchange Act of 1934 (the "Exchange Act"). 

OvaScience failed to release that the Company's AUGMENT procedure did not attain a substantial success rate of clinical pregnancies compared to former rates attained without the Company's AUGMENT procedure. Shareholders have suffered damages following the severe drop of OvaScience's common stock from initially being offered at $50 per share, to a recent close of just $8.74 per share on January 21, 2016.

If you are aware of any facts relating to this investigation, or purchased shares of OvaScience, you can assist this investigation by visiting the firm's website: http://www.bgandg.com/#!ovas/o6hyj. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email info@bgandg.com.  Those who inquire by e-mail are encouraged to include their mailing address, email and telephone number.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration.   Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-ovascience-inc-ovas-300208827.html